008930.KS KSC
Hanmi Science Co., Ltd.
1W: +6.1%
1M: +20.7%
3M: +80.4%
YTD: +22.9%
1Y: +27.6%
3Y: +79.2%
5Y: -22.6%
₩55,300.00 ($41.11)
+2600.00 (+4.93%)
Weekly Expected Move ±8.7%
₩45722
₩50511
₩55300
₩60089
₩64878
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$1.49T
+10.5% ▲
5Y CAGR: +10.1%
Total Liabilities
$527.0B
+3.3% ▲
5Y CAGR: +14.8%
Shareholders Equity
$966.2B
+14.9% ▲
5Y CAGR: +8.0%
Cash & Investments
$128.4B
+43.8% ▲
5Y CAGR: +53.6%
Total Debt
$226.9B
+4.4% ▲
5Y CAGR: +34.6%
Net Debt
$98.6B
-25.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $16.6B | $21.4B | $27.6B | $85.2B | $128.4B |
| Short-Term Investments | $39M | $93M | $6.9B | $4.0B | $0 |
| Cash & ST Investments | $16.6B | $21.5B | $34.5B | $89.2B | $128.4B |
| Net Receivables | $99.8B | $109.9B | $107.0B | $103.2B | $106.6B |
| Inventory | $106.0B | $112.2B | $104.9B | $108.7B | $122.5B |
| Other Current Assets | $0 | $678M | $27.3B | $20.8B | $22.3B |
| Total Current Assets | $222.6B | $245.3B | $273.9B | $328.0B | $385.3B |
| Property, Plant & Equip. | $26.0B | $88.9B | $94.1B | $100.4B | $109.2B |
| Goodwill & Intangibles | $7.6B | $19.1B | $67.1B | $54.5B | $52.7B |
| Long-Term Investments | $653.8B | $704.3B | $737.4B | $809.3B | $926.4B |
| Other Non-Current Assets | $37.0B | $50.9B | $53.7B | $55.1B | $14.8B |
| Total Non-Current Assets | $727.3B | $864.3B | $952.3B | $1.02T | $1.11T |
| Total Assets | $949.9B | $1.11T | $1.23T | $1.35T | $1.49T |
| — Liabilities — | |||||
| Accounts Payable | $104.6B | $77.6B | $59.8B | $111.8B | $116.7B |
| Short-Term Debt | $55.0B | $193.9B | $202.2B | $215.2B | $226.2B |
| Deferred Revenue | $60.1B | $31.9B | $0 | $0 | $60.5B |
| Other Current Liabilities | -$13.9B | $34.3B | $118.2B | $115.8B | $63.9B |
| Total Current Liabilities | $221.0B | $347.7B | $395.2B | $468.8B | $480.2B |
| Long-Term Debt | $0 | $5.8B | $10.2B | $350M | $0 |
| Other Non-Current Liab. | $23.8B | $16.6B | $17.3B | $25.2B | $27.0B |
| Total Non-Current Liabilities | $38.6B | $37.2B | $43.5B | $41.5B | $46.8B |
| Total Liabilities | $259.6B | $384.9B | $438.7B | $510.4B | $527.0B |
| — Equity — | |||||
| Common Stock | $33.7B | $34.3B | $35.0B | $35.0B | $35.0B |
| Retained Earnings | $397.1B | $461.2B | $328.2B | $410.5B | $479.6B |
| Accumulated OCI | -$34.2B | -$44.1B | -$45.6B | $208.7B | $263.5B |
| Total Stockholders Equity | $690.3B | $724.7B | $787.5B | $840.9B | $966.2B |
| Total Liabilities & Equity | $949.9B | $1.11T | $1.23T | $1.35T | $1.49T |
| — Key Metrics — | |||||
| Total Debt | $56.5B | $202.0B | $213.7B | $217.4B | $226.9B |
| Net Debt | $39.9B | $180.6B | $186.2B | $132.1B | $98.6B |
| Total Investments | $653.8B | $704.4B | $744.6B | $813.3B | $926.4B |